Literature-based discovery of diabetes- and ROS-related targets
暂无分享,去创建一个
H. V. Jagadish | Junguk Hur | H V Jagadish | David J States | Eva L Feldman | Adam D Schuyler | Manjusha Pande | Kelli A Sullivan | D. States | H. Jagadish | J. Hur | A. Schuyler | E. Feldman | Manjusha Pande | K. Sullivan | Yu Hong | Yu Hong
[1] David S. Wishart,et al. Nucleic Acids Research Polysearch: a Web-based Text Mining System for Extracting Relationships between Human Diseases, Genes, Mutations, Drugs Polysearch: a Web-based Text Mining System for Extracting Relationships between Human Diseases, Genes, Mutations, Drugs and Metabolites , 2008 .
[2] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[3] Plamen Nikolov,et al. Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.
[4] A. Koller,et al. PPARγ activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes , 2004 .
[5] F. DeRubertis,et al. Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol. , 2007, Metabolism: clinical and experimental.
[6] Adam D. Schuyler,et al. SciMiner: web-based literature mining tool for target identification and functional enrichment analysis , 2009, Bioinform..
[7] Dietrich Rebholz-Schuhmann,et al. EBIMed - text crunching to gather facts for proteins from Medline , 2007, Bioinform..
[8] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[9] E. Feldman,et al. Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms. , 2009, Antioxidants & redox signaling.
[10] M. Fujimura,et al. Exacerbation of delayed cell injury after transient global ischemia in mutant mice with CuZn superoxide dismutase deficiency. , 1999, Stroke.
[11] E. Feldman,et al. Mouse models of diabetic neuropathy , 2007, Neurobiology of Disease.
[12] E. Feldman. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. , 2003, The Journal of clinical investigation.
[13] R. Fisher. On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2010 .
[14] S. Marklund,et al. Enhanced diabetes-induced cataract in copper-zinc superoxide dismutase-null mice. , 2009, Investigative ophthalmology & visual science.
[15] Ş. Çetinkalp,et al. The effect of 1alpha,25(OH)2D3 vitamin over oxidative stress and biochemical parameters in rats where Type 1 diabetes is formed by streptozotocin. , 2009, Journal of diabetes and its complications.
[16] C. Jenkinson,et al. Proteomics Reveals Novel Oxidative and Glycolytic Mechanisms in Type 1 Diabetic Patients' Skin Which Are Normalized by Kidney-Pancreas Transplantation , 2010, PloS one.
[17] E. Sarsour,et al. Redox control of the cell cycle in health and disease. , 2009, Antioxidants & redox signaling.
[18] James S. Wright,et al. Targeted Deletion of the Cytosolic Cu/Zn-Superoxide Dismutase Gene (Sod1) Increases Susceptibility to Noise-Induced Hearing Loss , 1999, Audiology and Neurotology.
[19] C. Collinet,et al. Protein kinase C-α and -δ are required for NADPH oxidase activation in WKYMVm-stimulated IMR90 human fibroblasts , 2007 .
[20] D. Cleveland,et al. Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond , 2009, The Journal of cell biology.
[21] Yukita Sato,et al. Oxidative stress and gene expression of antioxidant enzymes in the streptozotocin-induced diabetic rats under hyperbaric oxygen exposure. , 2009, International journal of clinical and experimental pathology.
[22] Alfonso Valencia,et al. Overview of BioCreAtIvE: critical assessment of information extraction for biology , 2005, BMC Bioinformatics.
[23] C. Collinet,et al. Protein kinase C-alpha and -delta are required for NADPH oxidase activation in WKYMVm-stimulated IMR90 human fibroblasts. , 2007, Archives of biochemistry and biophysics.
[24] E. Feldman,et al. Dyslipidemia-Induced Neuropathy in Mice : the Role of oxLDL / LOX-1 , 2009 .
[25] A. Erol. Insulin resistance is an evolutionarily conserved physiological mechanism at the cellular level for protection against increased oxidative stress. , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.
[26] K. Talbot,et al. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS , 2008, Progress in Neurobiology.
[27] F. Hakim,et al. Role of oxidative stress in diabetic kidney disease. , 2010, Medical science monitor : international medical journal of experimental and clinical research.
[28] Jignesh M. Patel,et al. Michigan molecular interactions r2: from interacting proteins to pathways , 2008, Nucleic Acids Res..
[29] Jin-Shui Pan,et al. Reactive oxygen species: A double-edged sword in oncogenesis , 2009 .
[30] Ulf Leser,et al. ALIBABA: PubMed as a graph , 2006, Bioinform..
[31] G. V. Ommen,et al. Medical genomics , 2001, European Journal of Human Genetics.
[32] K. Kataoka,et al. Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese mice , 2010, Journal of hypertension.
[33] M. Gougerot-Pocidalo,et al. Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation. , 2002, Biochemistry.
[34] M. Aslan,et al. Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats. , 2003, The Journal of laboratory and clinical medicine.
[35] E. Feldman,et al. Oxidative stress in the pathogenesis of diabetic neuropathy. , 2004, Endocrine reviews.
[36] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[37] E. Feldman,et al. Diabetic neuropathy: mechanisms to management. , 2008, Pharmacology & therapeutics.
[38] E. Feldman,et al. New Insights into the Mechanisms of Diabetic Neuropathy , 2004, Reviews in Endocrine and Metabolic Disorders.
[39] A. Bokov,et al. Is the oxidative stress theory of aging dead? , 2009, Biochimica et biophysica acta.
[40] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[41] E. Schwedhelm,et al. Clinical Pharmacokinetics of Antioxidants and Their Impact on Systemic Oxidative Stress , 2003, Clinical pharmacokinetics.
[42] H. Ha,et al. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.
[43] R. Fisher. On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2018, Journal of the Royal Statistical Society Series A (Statistics in Society).
[44] A. Koller,et al. PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes. , 2004, American journal of physiology. Heart and circulatory physiology.
[45] J. Leahy. Economic Costs of Diabetes in the U.S. in 2007 , 2008 .
[46] Marina Vardanyan,et al. Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: Implications for chemical-induced peripheral sensory neuropathies , 2008, Molecular pain.
[47] M. Khazaei,et al. Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progression of diabetic renal disease in db/db mice. , 2009, American journal of physiology. Renal physiology.
[48] K. Takagi,et al. Increase in P-glycoprotein accompanied by activation of protein kinase Calpha and NF-kappaB p65 in the livers of rats with streptozotocin-induced diabetes. , 2008, Biochimica et biophysica acta.
[49] E. Feldman,et al. Oxidative injury and neuropathy in diabetes and impaired glucose tolerance , 2008, Neurobiology of Disease.
[50] M. Beal,et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.
[51] O. Yasuda,et al. Ezetimibe Ameliorates Cardiovascular Complications and Hepatic Steatosis in Obese and Type 2 Diabetic db/db Mice , 2010, Journal of Pharmacology and Experimental Therapeutics.
[52] P. Shaw,et al. Molecular and cellular pathways of neurodegeneration in motor neurone disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[53] E. Feldman,et al. Mechanisms of disease: The oxidative stress theory of diabetic neuropathy , 2008, Reviews in Endocrine and Metabolic Disorders.